Open Access

Articles selected from Faculty of 1000 in July 2003

Breast Cancer Research20035:E10

https://doi.org/10.1186/bcr630

Published: 1 October 2003

Articles selected from Faculty of 1000

Authors’ Affiliations

(1)
Molecular Medicine Unit, University of Leeds, St James's University Hospital

References

  1. Tetsu O, McCormick F: Proliferation of cancer cells despite CDK2 inhibition. Cancer Cell. 2003, 3: 233-245. For the Faculty of 1000 evaluation of this article please see http://breast-cancer-research.com/reports/bcr630.asp#tetsu View ArticlePubMedGoogle Scholar
  2. Fujita N, Jaye DL, Kajita M, Geigerman C, Moreno CS, Wade PA: MTA3, a Mi-2/NuRD complex subunit, regulates an invasive growth pathway in breast cancer. Cell. 2003, 113: 207-219. For the Faculty of 1000 evaluation of this article please see http://breast-cancer-research.com/reports/bcr630.asp#fujita View ArticlePubMedGoogle Scholar
  3. Bergamaschi D, Gasco M, Hiller L, Sullivan A, Syed N, Trigiante G, Yulug I, Merlano M, Numico G, Comino A, Attard M, Reelfs O, Gusterson B, Bell AK, Heath V, Tavassoli M, Farrell PJ, Smith P, Lu X, Crook T: Tp53 polymorphism influences response in cancer chemotherapy via modulation of p73-dependent apoptosis. Cancer Cell. 2003, 3: 387-402. For the Faculty of 1000 evaluation of this article please see http://breast-cancer-research.com/reports/bcr630.asp#bergamaschi View ArticlePubMedGoogle Scholar
  4. Irwin MS, Kondo K, Marin MC, Cheng LS, Hahn WC, Kaelin WG: Chemosensitivity linked to p73 function. Cancer Cell. 2003, 3: 403-410. For the Faculty of 1000 evaluation of this article please see http://breast-cancer-research.com/reports/bcr630.asp#irwin View ArticlePubMedGoogle Scholar

Copyright

© The Author(s) 2003

Advertisement